167 related articles for article (PubMed ID: 7194669)
1. The effect of O-(beta-hydroxyethyl)-rutosides (HR) on the skin capillary resistance of rats.
Gábor M
Arzneimittelforschung; 1981; 31(3):442-5. PubMed ID: 7194669
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
Kienzler JL; Sallin D; Schifflers MH; Ghika A
Eur J Clin Pharmacol; 2002 Sep; 58(6):395-402. PubMed ID: 12242598
[TBL] [Abstract][Full Text] [Related]
4. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
Gábor M
Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
[No Abstract] [Full Text] [Related]
5. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
[TBL] [Abstract][Full Text] [Related]
6. [Studies in animal experiments on determination of blood and organ levels of o-(beta-hydroxyethyl)-rutosides (HR) after i.p. administration (author's transl)].
Reinartz G; Wurst F
Arzneimittelforschung; 1980; 30(4):657-9. PubMed ID: 7190409
[TBL] [Abstract][Full Text] [Related]
7. [Chromatographic studies of four water-soluble rutosides].
Geissler VG
Arzneimittelforschung; 1975 Apr; 25(4):511-6. PubMed ID: 1174068
[TBL] [Abstract][Full Text] [Related]
8. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of O-(beta-hydroxyethyl)-rutosides (HR) against adriamycin-induced toxicity in rats.
Gulati OP; Nordmann H; Aellig A; Maignan MF; McGinness J
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):323-34. PubMed ID: 4004421
[TBL] [Abstract][Full Text] [Related]
10. The effect of O-(beta-hydroxyethyl)-rutosides on function and structure of the ganglion cells.
Blasius W; Leusser K; Merker G
Arzneimittelforschung; 1976; 26(9):1645-50. PubMed ID: 1036693
[TBL] [Abstract][Full Text] [Related]
11. Stimulation and inhibition of biosynthesis of prostaglandins in human skin by some hydroxyethylated rutosides.
Arturson G; Jonsson CE
Prostaglandins; 1975 Dec; 10(6):941-8. PubMed ID: 1208886
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
14. [Histochemical and ultrastructural studies on the anti-edema and radiation-protective effects of 0-(beta-hydroxyethyl)-rutosides in the rat brain after single-dose irradiation. 1. Electron microscopy study of terminal blood circulation].
Thiel HJ; Hammersen F; Sauer R
Strahlenther Onkol; 1988 Sep; 164(9):544-52. PubMed ID: 3175854
[TBL] [Abstract][Full Text] [Related]
15. Effect of Venoruton on the factor XIII activity in rat plasma.
Grochal M; Sempińska-Edelberg E; Plewiński J
Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
[TBL] [Abstract][Full Text] [Related]
16. [Reduction of radiation-induced late effects on vascular connective tissue of the skin (mouse paw) by o-(beta-hydroxyethyl)-rutoside].
Fritz-Niggli H; Fröhlich E
Rofo; 1979 May; 130(5):601-8. PubMed ID: 155632
[TBL] [Abstract][Full Text] [Related]
17. [Reduction of radiation-induced early skin damage (mouse foot) by O-(beta-hydroxyethyl)-rutoside (author's transl)].
Fritz-Niggli H; Fröhlich E
Rofo; 1980 Sep; 133(3):316-21. PubMed ID: 6451559
[TBL] [Abstract][Full Text] [Related]
18. [Histochemical and ultrastructural studies on anti-edematous and radiation-protective action of 0-(beta-hydroxyethyl)-rutosides on the rat brain after single irradiation. 2. Histochemical study on carbohydrate metabolism and acid phosphatase activation].
Thiel HJ; Lierse W; Lehmann FM; Sauer R
Strahlenther Onkol; 1988 Nov; 164(11):662-73. PubMed ID: 3201383
[TBL] [Abstract][Full Text] [Related]
19. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
Dobbins DE; Soika CY; Dabney JM
Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155
[TBL] [Abstract][Full Text] [Related]
20. Effect of o-(beta-hydroxyethyl)-rutosides on the microrheology of human blood under defined flow conditions.
Schmid-Schönbein H; Volger E; Weiss J; Brandhuber M
Vasa; 1975; 4(3):263-70. PubMed ID: 1179829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
